Open AccessIncidence of leukopenia after intraperitonealvscombined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei
Author(s) -
Philipp Horvath,
Stefan Beckert,
Florian Struller,
Alfred Königsrainer,
Ingmar Königsrainer
Publication year - 2016
Publication title -
world journal of gastrointestinal pharmacology and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2150-5349
DOI - 10.4292/wjgpt.v7.i3.434
Subject(s) - leukopenia , medicine , surgery , pseudomyxoma peritonei , incidence (geometry) , mitomycin c , oxaliplatin , hyperthermic intraperitoneal chemotherapy , gastroenterology , chemotherapy , cancer , colorectal cancer , appendix , ovarian cancer , cytoreductive surgery , paleontology , physics , optics , biology
To investigate the clinical impact of post-hyperthermic intraperitoneal chemotherapy (HIPEC) leukopenia, intraperitoneal and combined intravenous/intraperitoneal drug administrations were compared.